Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash $ 6,219,231 $ 8,222,119
Prepaid expenses and other current assets 328,284 238,040
Total current assets 6,547,515 8,460,159
Other assets 692,937 36,271
Total assets 7,240,452 8,496,430
Current liabilities    
Accounts payable 2,352,809 1,738,837
Accrued expenses and other current liabilities 1,386,773 1,330,746
Total current liabilities 11,878,582 10,972,583
Total liabilities 11,878,582 10,972,583
COMMITMENT AND CONTINGENCIES (NOTE 9)  
Stockholders' Equity (Deficit)    
Common Stock, par value, $0.001; 100,000,000 shares authorized, 40,478,861 and 27,142,979 shares issued and outstanding as of December 31, 2019 and 2018, respectively 40,479 27,143
Additional paid-in capital 47,553,977 32,619,282
Accumulated deficit (53,714,751) (36,992,911)
Total PAVmed Inc. stockholders' equity (deficit) (3,823,851) (2,314,641)
Noncontrolling interest in majority-owned subsidiaries (814,279) (161,512)
Total deficit (4,638,130) (2,476,153)
Total Liabilities and Equity (Deficit) 7,240,452 8,496,430
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock, par value $0.001, 20,000,000 shares authorized; 2,296,444 2,031,845
Senior Secured Convertible Note Issued on December 27, 2018 [Member]    
Current liabilities    
Senior Secured Convertible Note issued at fair value, face value principal at December 31, 2019 and 2018, respectively 1,700,000 7,903,000
Senior Secured Convertible Note Issued on November 4, 2019 [Member]    
Current liabilities    
Senior Secured Convertible Note issued at fair value, face value principal at December 31, 2019 and 2018, respectively $ 6,439,000